FDA.reportPublic FDA data

isoflupredone / neomycin / tetracaine Topical Powder

RxCUI
1551410
RxNorm name
isoflupredone / neomycin / tetracaine Topical Powder
Term type
SCDF
Status
Active
Updated
2026-10-13 14:25:33

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
112014
Active start
112014
Multiple ingredient
YES
Branded
NO

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Topical Powder317009

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
tetracaine10391
isoflupredone1546449
neomycin7299

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
RXNAV_STRisoflupredone / neomycin / tetracaine Topical Powder1NAMES
RxNorm Nameisoflupredone / neomycin / tetracaine Topical Powder1NAMES
TTYSCDF1ATTRIBUTES
RxCUI15514101CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCD04ABAnesthetics for topical useATC1-4tetracaine
ATCA07AAAntibioticsATC1-4neomycin
ATCS01AAAntibioticsATC1-4neomycin
ATCR02ABAntibioticsATC1-4neomycin
ATCB05CAAntiinfectivesATC1-4neomycin
ATCS03AAAntiinfectivesATC1-4neomycin
ATCS02AAAntiinfectivesATC1-4neomycin
ATCA01ABAntiinfectives and antiseptics for local oral treatmentATC1-4neomycin
ATCN01BAEsters of aminobenzoic acidATC1-4tetracaine
ATCC05ADLocal anestheticsATC1-4tetracaine
ATCS01HALocal anestheticsATC1-4tetracaine
ATCJ01GBOther aminoglycosidesATC1-4neomycin
ATCD06AXOther antibiotics for topical useATC1-4neomycin
FDASPLD000617AminoglycosidesCHEMhas_chemical_structureneomycin
FDASPLD004952EstersCHEMhas_chemical_structuretetracaine
FDASPLN0000175477Aminoglycoside AntibacterialEPChas_epcneomycin
FDASPLN0000175683Ester Local AnestheticEPChas_epctetracaine
FDASPLN0000175976Local AnesthesiaPEhas_petetracaine
MEDRTD005477FluprednisoloneCHEMhas_ingredientisoflupredone acetate
MEDRTD005477FluprednisoloneCHEMhas_ingredientisoflupredone
MEDRTD009355NeomycinCHEMhas_ingredientneomycin
MEDRTD013748TetracaineCHEMhas_ingredienttetracaine
MEDRTD001424Bacterial InfectionsDISEASEmay_preventneomycin
MEDRTD004342Drug HypersensitivityDISEASEci_withtetracaine hydrochloride
MEDRTD004342Drug HypersensitivityDISEASEci_withtetracaine
MEDRTD004342Drug HypersensitivityDISEASEci_withneomycin
MEDRTD004927Escherichia coli InfectionsDISEASEmay_treatneomycin
MEDRTD006501Hepatic EncephalopathyDISEASEmay_treatneomycin
MEDRTD015212Inflammatory Bowel DiseasesDISEASEci_withneomycin
MEDRTD007415Intestinal ObstructionDISEASEci_withneomycin
MEDRTD010146PainDISEASEmay_treattetracaine
MEDRTD010146PainDISEASEmay_preventtetracaine
MEDRTD010146PainDISEASEmay_preventtetracaine hydrochloride
MEDRTD010146PainDISEASEmay_treattetracaine hydrochloride
MEDRTD017192Skin Diseases, BacterialDISEASEmay_treatneomycin
MEDRTN0000000150Protein Synthesis InhibitorsMOAhas_moaneomycin
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moatetracaine
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moatetracaine hydrochloride
MEDRTN0000008841Decreased Protein SynthesisPEhas_peneomycin
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_petetracaine
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_petetracaine hydrochloride
MEDRTN0000175976Local AnesthesiaPEhas_petetracaine
MEDRTN0000175976Local AnesthesiaPEhas_petetracaine hydrochloride

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESRXNAV_VET_DRUGUS